Funding Momentum Akido Labs closed a $60M Series B in 2025 led by Oak HC/FT, with participation from existing investors. This funding supports rapid expansion of Scope AI and its provider network, indicating strong capital availability for enterprise deployments and integration projects with health systems. The company reports revenue in the $50-100M range, signaling scale and commercial traction.

AI Driven Care Core product Scope AI and a mission to reimagine care create opportunities to pitch AI powered triage, risk stratification, care coordination, and remote monitoring to large hospital systems and health networks. With expansion of its provider network across California, Rhode Island, and New York, there is a need for interoperability with EHRs and data analytics platforms.

Network Growth Strategic hires to scale the network: Chief Network Officer Matt Siegler leading growth and operations, and Board appointment of Jack Greco signals a governance and scale focus. This suggests readiness for enterprise sales cycles targeting hospital networks, clinics, and accountable care organizations needing network management, provider onboarding, referral networks, and payer relationships.

Community Health Partnership with Future Communities Inc and HOPICS to launch a street medicine program serving over 5,000 patients demonstrates experience in delivering care outside traditional settings. BD opportunities include mobile clinic tech, patient data capture, SDoH analytics, outcomes tracking, and potential expansions to new cities or grant funded programs.

Compliance Security HIPAA-compliant tech stack and appointment of a Chief Communications Officer indicate emphasis on privacy, security, and stakeholder communications. This positions Akido as a partner for health systems that require robust data governance, vendor risk management, and secure data sharing in multi vendor environments.